Regeneron co-Chair, President and CSO George Yancopoulos discusses the company’s planned weight-loss drugs with Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco. (Source: Bloomberg)
Regeneron CSO Yancopoulos on Weight-Loss Drugs, Pipeline
You May Also Like
Walmart founder Sam Walton’s business advice
January 15, 2025
Meta Plans to Cut Roughly 5% of Staff
January 15, 2025
+ There are no comments
Add yours